KEYNOTE-365 cohort A updated results: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
暂无分享，去创建一个
A. Tafreshi | J. Bono | S. Oudard | G. Gravis | E. Yu | M. Retz | W. Berry | J. D. de Bono | J. Piulats | P. Fong | H. Gurney | C. Poehlein | B. Laguerre | S. Feyerabend | N. Mar | J. A. Arija | M. Kolinsky | A. Kam | J. A. Arranz Arija | Helen Wu | C. Schloss | M. Augustin | Audrey E. Kam